PMID: 9658139Jul 11, 1998Paper

Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?

Journal of Virology
Patrick C ReadingE M Anders

Abstract

The influence of diabetes on susceptibility to influenza virus infection was examined in a mouse model in which RIP-Kb transgenic mice and their nontransgenic littermates were used as the diabetic and nondiabetic hosts, respectively. Influenza virus A/Phil/82 (H3N2) grew to significantly higher titers in the lungs of diabetic than nondiabetic mice. The extent of viral replication in the lungs was proportional to blood glucose levels in the mice at the time of infection, and the enhanced susceptibility of diabetic mice was reversed with insulin. Growth of A/HKx31 (H3N2) virus was also enhanced in diabetic mice, whereas the highly virulent strain A/PR/8/34 (H1N1) showed no difference in virus yields in diabetic and nondiabetic mice, even with low inocula. A/Phil/82 and A/HKx31 are sensitive to neutralization in vitro by the pulmonary collectin surfactant protein D (SP-D), whereas A/PR/8/34 is essentially resistant. Glucose is a ligand for SP-D, and neutralization of A/Phil/82 virus by SP-D was abolished in the presence of glucose at levels commonly found in diabetic mice. These findings suggest that in mice, and perhaps in humans, diabetes predisposes to influenza virus infection through compromise of collectin-mediated host defe...Continue Reading

References

Jan 1, 1992·Annual Review of Immunology·P C DohertyS R Carding
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J AllisonJ F Miller
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E M AndersD C Jackson
Aug 1, 1990·Diabetes Care·R J DieperslootJ B Hoekstra
Aug 1, 1994·Protein Science : a Publication of the Protein Society·H J Hoppe, K B Reid
Jul 1, 1994·The Journal of Clinical Investigation·K L HartshornK Sastry
Feb 1, 1994·Immunology Today·U HolmskovJ C Jensenius

❮ Previous
Next ❯

Citations

Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M R WhiteK L Hartshorn
Nov 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G EngelichK L Hartshorn
Jun 6, 2012·Journal of Biomedicine & Biotechnology·Wy Ching NgPatrick C Reading
Sep 18, 2015·Clinical and Vaccine Immunology : CVI·Yu Bin SeoWoo Joo Kim
Mar 27, 2020·MBio·Rebecca J MarshallKirsty R Short
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·R Kandel, K L Hartshorn
Jan 21, 2010·Diabetes Care·José Manuel Fernández-RealWifredo Ricart
Aug 23, 2006·The Proceedings of the Nutrition Society·Emma H BakerBarbara J Philips
Jun 23, 2007·American Journal of Respiratory Cell and Molecular Biology·Gregory W MartensHardy Kornfeld
Nov 13, 2013·Innate Immunity·Shweta TripathiKevan L Hartshorn
Jun 9, 2016·Scientific Reports·Simren K GillJohn S Tregoning
May 22, 2020·Wiener klinische Wochenschrift·Slobodan Peric, Thomas M Stulnig
Oct 23, 2001·Respiratory Research·E C Crouch
Jul 1, 2008·Expert Review of Clinical Immunology·Mitchell R WhiteKevan L Hartshorn
Jul 15, 2020·Journal of Virology·Maria SmithStacey Schultz-Cherry
Sep 13, 2006·Veterinary Pathology·B GruborM R Ackermann
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M van EijkA Archibold
Feb 19, 2010·Clinical and Vaccine Immunology : CVI·Abbas JamaliMasume Tavasoti Kheiri
Mar 13, 2020·Cellular & Molecular Biology Letters·Mohsen KeshavarzFarhad Rezaei
Dec 11, 2020·Journal of Clinical Medicine·Yu-Huang LiaoYou-Chen Chao
Nov 17, 2020·Frontiers in Cellular and Infection Microbiology·Kevan L Hartshorn
Feb 23, 2021·Frontiers in Immunology·Deepak SumbriaBarry T Rouse
Jun 8, 2017·Frontiers in Microbiology·Katina D HulmeKirsty R Short
Dec 16, 2018·Bioscience Reports·Ian A YorkIrina V Alymova
Feb 24, 2018·Frontiers in Medicine·Grith L Sorensen
Feb 27, 1999·Current Opinion in Immunology·A J Tenner
Feb 27, 1999·Current Opinion in Immunology·P Eggleton, K B Reid
Dec 15, 2016·MBio·Michelle E Mulcahy, Rachel M McLoughlin
Jun 29, 2021·Journal of Taibah University Medical Sciences·Waleed H Albuali, Nora A AlGhamdi
Jul 16, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Amit K VermaYamini Goyal
Aug 17, 2021·Frontiers in Public Health·Emmanuelle LogetteHenry Markram
Oct 2, 2021·Frontiers in Cellular and Infection Microbiology·Jane E SinclairKirsty R Short

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
B SchaubPatricia W Finn
American Journal of Respiratory and Critical Care Medicine
Machiko IkegamiJeffrey A Whitsett
American Journal of Respiratory and Critical Care Medicine
Deepika JainMichael F Beers
© 2022 Meta ULC. All rights reserved